Agenus stock cut at Baird on FDA feedback (NASDAQ:AGEN)
George Clerc After falling nearly 60% in the previous session, Agenus shares (NASDAQ: Agen) Decreased by ~5% Shares of Baird fell Friday after the company downgraded its rating, citing FDA reactions to its colorectal cancer treatment…
